Clinical Trial Update: Intraperitoneal Paclitaxel Plus Systemic mFOLFOX6 [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating intraperitoneal paclitaxel with systemic mFOLFOX6 in gastric cancer with peritoneal carcinomatosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Peritoneal Carcinomatosis

Drugs mentioned

• Intraperitoneal Paclitaxel (paclitaxel)
• MFOLFOX6

Snippet

Sponsor: Seoul National University Bundang Hospital | Conditions: Gastric Cancer Stage IV, Peritoneal Carcinomatosis | Phase 1, Phase 2 | Status: COMPLETED